Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/5194
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHolscher, Hannah D-
dc.contributor.authorBruno P, Chumpitazi-
dc.contributor.authorWendy J, Dahl-
dc.contributor.authorGeorge C, Fahey-
dc.contributor.authorDeAnn J, Liska-
dc.contributor.authorJoanne L, Slavin-
dc.contributor.authorKristin, Verbeke-
dc.date.accessioned2023-08-01T03:55:11Z-
dc.date.available2023-08-01T03:55:11Z-
dc.date.issued2022-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/5194-
dc.description.abstractHuman intestinal enzymes do not hydrolyze nondigestible carbohydrates (NDCs), and thus, they are not digested and absorbed in the small intestine. Instead, NDCs are partially to completely fermented by the intestinal microbiota. Select NDCs are associated with health benefits such as laxation and lowering of blood cholesterol and glucose. NDCs provide functional attributes to processed foods, including sugar or fat replacers, thickening agents, and bulking agents. Additionally, NDCs are incorporated into processed foods to increase their fiber content. Although consumption of NDCs can benefit health and contribute functional characteristics to foods, they can cause gastrointestinal symptoms, such as flatulence and bloating. As gastrointestinal symptoms negatively affect consumer well-being and their acceptance of foods containing NDC ingredients, it is crucial to consider tolerance when designing food products and testing their physiological health benefits in clinical trials. This perspective provides recommendations for the approach to assess gastrointestinal tolerance to NDCs, with a focus on study design, population criteria, intervention, comparator, and outcome. Special issues related to studies in children and implications for stakeholders are also discussed. It is recommended that the evaluation of gastrointestinal tolerance to NDCs be conducted in randomized, blinded, controlled crossover studies using standard gastrointestinal questionnaires, with attention to study participant background diets, health status, lifestyle, and medicationsen_US
dc.language.isoen_USen_US
dc.subjectdietary fiberen_US
dc.subjectoligosaccharidesen_US
dc.subjectlow-digestible carbohydratesen_US
dc.subjectlaxationen_US
dc.subjectgastrointestinal intoleranceen_US
dc.titlePerspective: Assessing Tolerance to Nondigestible Carbohydrate Consumptionen_US
dc.typeArticleen_US
Appears in Collections:VOL 13 NO 6 2022

Files in This Item:
File Description SizeFormat 
2084-2097.pdf704.75 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.